Regenerx Biopharmaceuticals Inc (RGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,728 | -1,598 | -1,523 | -1,404 | -1,994 |
| Depreciation Amortization | N/A | N/A | N/A | 1 | 3 |
| Accounts payable and accrued liabilities | 0 | 24 | -4 | -49 | 26 |
| Other Working Capital | 39 | 30 | 22 | -110 | 178 |
| Other Operating Activity | 747 | 553 | 499 | 424 | 899 |
| Operating Cash Flow | $-941 | $-990 | $-1,007 | $-1,138 | $-888 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 555 | 1,300 | N/A |
| Common Stock Issued | N/A | 1,794 | 242 | 241 | 1,029 |
| Other Financing Activity | 0 | 0 | -2 | 0 | -86 |
| Financing Cash Flow | $N/A | $1,794 | $795 | $1,541 | $944 |
| Beginning Cash Position | 1,232 | 428 | 640 | 237 | 182 |
| End Cash Position | 291 | 1,232 | 428 | 640 | 237 |
| Net Cash Flow | $-941 | $804 | $-212 | $403 | $56 |
| Free Cash Flow | |||||
| Operating Cash Flow | -941 | -990 | -1,007 | -1,138 | -888 |
| Free Cash Flow | -941 | -990 | -1,007 | -1,138 | -888 |